0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs for Malaria Market Insights and Forecast to 2027
Published Date: May 2021
|
Report Code: QYRE-Auto-O228
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Drugs for Malaria Market Insights and Forecast to 2027

Global Drugs for Malaria Market Insights and Forecast to 2027

Code: QYRE-Auto-O228
Report
May 2021
118 Pages
QYResearch
Region: Global, United States,
Description
Table of Content
Tables & Figures
Drugs for Malaria market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Malaria market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds

Segment by Application

Prevention
Treatment
Others

BY COMPANY

Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
1 Study Coverage
1.1 Drugs for Malaria Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type
1.4.2 Aryl Aminoalcohol Compounds
1.4.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Market by Application
1.3.1 Global Drugs for Malaria Market Size Growth Rate by Application
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Malaria Sales Estimates and Forecasts 2016-2027
2.2 Global Drugs for Malaria Revenue Estimates and Forecasts 2016-2027
2.3 Global Drugs for Malaria Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Drugs for Malaria Regions by Sales
2.4.1 Global Top Drugs for Malaria Regions by Sales (2016-2021)
2.4.2 Global Top Drugs for Malaria Regions by Sales (2022-2027)
2.5 Global Top Drugs for Malaria Regions by Revenue
2.5.1 Global Top Drugs for Malaria Regions by Revenue (2016-2021)
2.5.2 Global Top Drugs for Malaria Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drugs for Malaria Sales by Manufacturers
3.1.1 Global Top Drugs for Malaria Manufacturers by Sales (2016-2021)
3.1.2 Global Top Drugs for Malaria Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Drugs for Malaria Sales in 2020
3.2 Global Drugs for Malaria Revenue by Manufacturers
3.2.1 Global Top Drugs for Malaria Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Drugs for Malaria Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Drugs for Malaria Revenue in 2020
3.3 Global Drugs for Malaria Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drugs for Malaria Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drugs for Malaria Sales by Type
4.1.1 Global Drugs for Malaria Historical Sales by Type (2016-2021)
4.1.2 Global Drugs for Malaria Forecasted Sales by Type (2022-2027)
4.1.3 Global Drugs for Malaria Sales Market Share by Type (2016-2027)
4.2 Global Drugs for Malaria Revenue by Type
4.2.1 Global Drugs for Malaria Historical Revenue by Type (2016-2021)
4.2.2 Global Drugs for Malaria Forecasted Revenue by Type (2022-2027)
4.2.3 Global Drugs for Malaria Revenue Market Share by Type (2016-2027)
4.3 Global Drugs for Malaria Price by Type
4.3.1 Global Drugs for Malaria Price by Type (2016-2021)
4.3.2 Global Drugs for Malaria Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Drugs for Malaria Sales by Application
5.1.1 Global Drugs for Malaria Historical Sales by Application (2016-2021)
5.1.2 Global Drugs for Malaria Forecasted Sales by Application (2022-2027)
5.1.3 Global Drugs for Malaria Sales Market Share by Application (2016-2027)
5.2 Global Drugs for Malaria Revenue by Application
5.2.1 Global Drugs for Malaria Historical Revenue by Application (2016-2021)
5.2.2 Global Drugs for Malaria Forecasted Revenue by Application (2022-2027)
5.2.3 Global Drugs for Malaria Revenue Market Share by Application (2016-2027)
5.3 Global Drugs for Malaria Price by Application
5.3.1 Global Drugs for Malaria Price by Application (2016-2021)
5.3.2 Global Drugs for Malaria Price Forecast by Application (2022-2027)
6 North America
6.1 North America Drugs for Malaria Market Size by Type
6.1.1 North America Drugs for Malaria Sales by Type (2016-2027)
6.1.2 North America Drugs for Malaria Revenue by Type (2016-2027)
6.2 North America Drugs for Malaria Market Size by Application
6.2.1 North America Drugs for Malaria Sales by Application (2016-2027)
6.2.2 North America Drugs for Malaria Revenue by Application (2016-2027)
6.3 North America Drugs for Malaria Market Size by Country
6.3.1 North America Drugs for Malaria Sales by Country (2016-2027)
6.3.2 North America Drugs for Malaria Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Drugs for Malaria Market Size by Type
7.1.1 Europe Drugs for Malaria Sales by Type (2017-2027)
7.1.2 Europe Drugs for Malaria Revenue by Type (2017-2027)
7.2 Europe Drugs for Malaria Market Size by Application
7.2.1 Europe Drugs for Malaria Sales by Application (2017-2027)
7.2.2 Europe Drugs for Malaria Revenue by Application (2017-2027)
7.3 Europe Drugs for Malaria Market Size by Country
7.3.1 Europe Drugs for Malaria Sales by Country (2017-2027)
7.3.2 Europe Drugs for Malaria Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drugs for Malaria Market Size by Type
8.1.1 Asia Pacific Drugs for Malaria Sales by Type (2018-2027)
8.1.2 Asia Pacific Drugs for Malaria Revenue by Type (2018-2027)
8.2 Asia Pacific Drugs for Malaria Market Size by Application
8.2.1 Asia Pacific Drugs for Malaria Sales by Application (2018-2027)
8.2.2 Asia Pacific Drugs for Malaria Revenue by Application (2018-2027)
8.3 Asia Pacific Drugs for Malaria Market Size by Region
8.3.1 Asia Pacific Drugs for Malaria Sales by Region (2018-2027)
8.3.2 Asia Pacific Drugs for Malaria Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Drugs for Malaria Market Size by Type
9.1.1 Latin America Drugs for Malaria Sales by Type (2019-2027)
9.1.2 Latin America Drugs for Malaria Revenue by Type (2019-2027)
9.2 Latin America Drugs for Malaria Market Size by Application
9.2.1 Latin America Drugs for Malaria Sales by Application (2019-2027)
9.2.2 Latin America Drugs for Malaria Revenue by Application (2019-2027)
9.3 Latin America Drugs for Malaria Market Size by Country
9.3.1 Latin America Drugs for Malaria Sales by Country (2019-2027)
9.3.2 Latin America Drugs for Malaria Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Drugs for Malaria Market Size by Type
6.1.1 Middle East and Africa Drugs for Malaria Sales by Type (2016-2027)
6.1.2 Middle East and Africa Drugs for Malaria Revenue by Type (2016-2027)
6.2 Middle East and Africa Drugs for Malaria Market Size by Application
6.2.1 Middle East and Africa Drugs for Malaria Sales by Application (2016-2027)
6.2.2 Middle East and Africa Drugs for Malaria Revenue by Application (2016-2027)
6.3 Middle East and Africa Drugs for Malaria Market Size by Country
6.3.1 Middle East and Africa Drugs for Malaria Sales by Country (2016-2027)
6.3.2 Middle East and Africa Drugs for Malaria Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Overview
11.1.3 Cipla Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Cipla Drugs for Malaria Product Description
11.1.5 Cipla Related Developments
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Corporation Information
11.2.2 Guilin Pharmaceutical Overview
11.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Guilin Pharmaceutical Drugs for Malaria Product Description
11.2.5 Guilin Pharmaceutical Related Developments
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Corporation Information
11.3.2 IPCA Laboratories Overview
11.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 IPCA Laboratories Drugs for Malaria Product Description
11.3.5 IPCA Laboratories Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 GlaxoSmithKline Drugs for Malaria Product Description
11.4.5 GlaxoSmithKline Related Developments
11.5 Mylan Labs
11.5.1 Mylan Labs Corporation Information
11.5.2 Mylan Labs Overview
11.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Mylan Labs Drugs for Malaria Product Description
11.5.5 Mylan Labs Related Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Roche Drugs for Malaria Product Description
11.6.5 Roche Related Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Overview
11.7.3 Novartis Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Novartis Drugs for Malaria Product Description
11.7.5 Novartis Related Developments
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Corporation Information
11.8.2 Sanofi Aventis Overview
11.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sanofi Aventis Drugs for Malaria Product Description
11.8.5 Sanofi Aventis Related Developments
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Corporation Information
11.9.2 Ajanta Pharma Overview
11.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Ajanta Pharma Drugs for Malaria Product Description
11.9.5 Ajanta Pharma Related Developments
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Overview
11.1.3 Cipla Drugs for Malaria Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Cipla Drugs for Malaria Product Description
11.1.5 Cipla Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Drugs for Malaria Value Chain Analysis
12.2 Drugs for Malaria Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drugs for Malaria Production Mode & Process
12.4 Drugs for Malaria Sales and Marketing
12.4.1 Drugs for Malaria Sales Channels
12.4.2 Drugs for Malaria Distributors
12.5 Drugs for Malaria Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drugs for Malaria Industry Trends
13.2 Drugs for Malaria Market Drivers
13.3 Drugs for Malaria Market Challenges
13.4 Drugs for Malaria Market Restraints
14 Key Findings in The Global Drugs for Malaria Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Drugs for Malaria Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Aryl Aminoalcohol Compounds
    Table 3. Major Manufacturers of Antifolate Compounds
    Table 4. Major Manufacturers of Artemisinin Compounds
    Table 5. Global Drugs for Malaria Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 6. Global Drugs for Malaria Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Drugs for Malaria Sales by Region (2016-2021) & (K Units)
    Table 8. Global Drugs for Malaria Sales Market Share by Region (2016-2021)
    Table 9. Global Drugs for Malaria Sales by Region (2016-2021) & (K Units)
    Table 10. Global Drugs for Malaria Sales Market Share by Region (2022-2027)
    Table 11. Global Drugs for Malaria Revenue by Region (2016-2021) & (US$ Million)
    Table 12. Global Drugs for Malaria Revenue Market Share by Region (2016-2021)
    Table 13. Global Drugs for Malaria Revenue by Region (2022-2027) & (US$ Million)
    Table 14. Global Drugs for Malaria Revenue Market Share by Region (2022-2027)
    Table 15. Global Drugs for Malaria Sales by Manufacturers (2016-2021) & (K Units)
    Table 16. Global Drugs for Malaria Sales Share by Manufacturers (2016-2021)
    Table 17. Global Drugs for Malaria Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 18. Global Drugs for Malaria Revenue Share by Manufacturers (2016-2021)
    Table 19. Drugs for Malaria Price by Manufacturers 2016-2021 (USD/Unit)
    Table 20. Global Drugs for Malaria Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Drugs for Malaria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Malaria as of 2020)
    Table 22. Drugs for Malaria Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Drugs for Malaria Product Offered
    Table 24. Date of Manufacturers Enter into Drugs for Malaria Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drugs for Malaria Sales by Type (2016-2021) & (K Units)
    Table 27. Global Drugs for Malaria Sales by Type (2022-2027) & (K Units)
    Table 28. Global Drugs for Malaria Sales Share by Type (2016-2021)
    Table 29. Global Drugs for Malaria Sales Share by Type (2022-2027)
    Table 30. Global Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
    Table 31. Global Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
    Table 32. Global Drugs for Malaria Revenue Share by Type (2016-2021)
    Table 33. Global Drugs for Malaria Revenue Share by Type (2022-2027)
    Table 34. Drugs for Malaria Price by Type (2016-2021) & (USD/Unit)
    Table 35. Global Drugs for Malaria Price Forecast by Type (2022-2027) & (USD/Unit)
    Table 36. Global Drugs for Malaria Sales by Application (2016-2021) & (K Units)
    Table 37. Global Drugs for Malaria Sales by Application (2022-2027) & (K Units)
    Table 38. Global Drugs for Malaria Sales Share by Application (2016-2021)
    Table 39. Global Drugs for Malaria Sales Share by Application (2022-2027)
    Table 40. Global Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
    Table 41. Global Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
    Table 42. Global Drugs for Malaria Revenue Share by Application (2016-2021)
    Table 43. Global Drugs for Malaria Revenue Share by Application (2022-2027)
    Table 44. Drugs for Malaria Price by Application (2016-2021) & (USD/Unit)
    Table 45. Global Drugs for Malaria Price Forecast by Application (2022-2027) & (USD/Unit)
    Table 46. North America Drugs for Malaria Sales by Type (2016-2021) & (K Units)
    Table 47. North America Drugs for Malaria Sales by Type (2022-2027) & (K Units)
    Table 48. North America Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
    Table 49. North America Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
    Table 50. North America Drugs for Malaria Sales by Application (2016-2021) & (K Units)
    Table 51. North America Drugs for Malaria Sales by Application (2022-2027) & (K Units)
    Table 52. North America Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
    Table 53. North America Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
    Table 54. North America Drugs for Malaria Sales by Country (2016-2021) & (K Units)
    Table 55. North America Drugs for Malaria Sales by Country (2022-2027) & (K Units)
    Table 56. North America Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
    Table 57. North America Drugs for Malaria Revenue by Country (2022-2027) & (US$ Million)
    Table 58. Europe Drugs for Malaria Sales by Type (2016-2021) & (K Units)
    Table 59. Europe Drugs for Malaria Sales by Type (2022-2027) & (K Units)
    Table 60. Europe Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
    Table 61. Europe Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
    Table 62. Europe Drugs for Malaria Sales by Application (2016-2021) & (K Units)
    Table 63. Europe Drugs for Malaria Sales by Application (2022-2027) & (K Units)
    Table 64. Europe Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
    Table 65. Europe Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
    Table 66. Europe Drugs for Malaria Sales by Country (2016-2021) & (K Units)
    Table 67. Europe Drugs for Malaria Sales by Country (2022-2027) & (K Units)
    Table 68. Europe Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
    Table 69. Europe Drugs for Malaria Revenue by Country (2022-2027) & (US$ Million)
    Table 70. Asia Pacific Drugs for Malaria Sales by Type (2016-2021) & (K Units)
    Table 71. Asia Pacific Drugs for Malaria Sales by Type (2022-2027) & (K Units)
    Table 72. Asia Pacific Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
    Table 73. Asia Pacific Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
    Table 74. Asia Pacific Drugs for Malaria Sales by Application (2016-2021) & (K Units)
    Table 75. Asia Pacific Drugs for Malaria Sales by Application (2022-2027) & (K Units)
    Table 76. Asia Pacific Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
    Table 77. Asia Pacific Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
    Table 78. Asia Pacific Drugs for Malaria Sales by Region (2016-2021) & (K Units)
    Table 79. Asia Pacific Drugs for Malaria Sales by Region (2022-2027) & (K Units)
    Table 80. Asia Pacific Drugs for Malaria Revenue by Region (2016-2021) & (US$ Million)
    Table 81. Asia Pacific Drugs for Malaria Revenue by Region (2022-2027) & (US$ Million)
    Table 82. Latin America Drugs for Malaria Sales by Type (2016-2021) & (K Units)
    Table 83. Latin America Drugs for Malaria Sales by Type (2022-2027) & (K Units)
    Table 84. Latin America Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
    Table 85. Latin America Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
    Table 86. Latin America Drugs for Malaria Sales by Application (2016-2021) & (K Units)
    Table 87. Latin America Drugs for Malaria Sales by Application (2022-2027) & (K Units)
    Table 88. Latin America Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
    Table 89. Latin America Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
    Table 90. Latin America Drugs for Malaria Sales by Country (2016-2021) & (K Units)
    Table 91. Latin America Drugs for Malaria Sales by Country (2022-2027) & (K Units)
    Table 92. Latin America Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
    Table 93. Latin America Drugs for Malaria Revenue by Country (2022-2027) & (US$ Million)
    Table 94. Middle East and Africa Drugs for Malaria Sales by Type (2016-2021) & (K Units)
    Table 95. Middle East and Africa Drugs for Malaria Sales by Type (2022-2027) & (K Units)
    Table 96. Middle East and Africa Drugs for Malaria Revenue by Type (2016-2021) & (US$ Million)
    Table 97. Middle East and Africa Drugs for Malaria Revenue by Type (2022-2027) & (US$ Million)
    Table 98. Middle East and Africa Drugs for Malaria Sales by Application (2016-2021) & (K Units)
    Table 99. Middle East and Africa Drugs for Malaria Sales by Application (2022-2027) & (K Units)
    Table 100. Middle East and Africa Drugs for Malaria Revenue by Application (2016-2021) & (US$ Million)
    Table 101. Middle East and Africa Drugs for Malaria Revenue by Application (2022-2027) & (US$ Million)
    Table 102. Middle East and Africa Drugs for Malaria Sales by Country (2016-2021) & (K Units)
    Table 103. Middle East and Africa Drugs for Malaria Sales by Country (2022-2027) & (K Units)
    Table 104. Middle East and Africa Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
    Table 105. Middle East and Africa Drugs for Malaria Revenue by Country (2022-2027) & (US$ Million)
    Table 106. Cipla Corporation Information
    Table 107. Cipla Description and Major Businesses
    Table 108. Cipla Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 109. Cipla Drugs for Malaria Product
    Table 110. Cipla Recent Developments
    Table 111. Guilin Pharmaceutical Corporation Information
    Table 112. Guilin Pharmaceutical Description and Major Businesses
    Table 113. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 114. Guilin Pharmaceutical Drugs for Malaria Product
    Table 115. Guilin Pharmaceutical Recent Developments
    Table 116. IPCA Laboratories Corporation Information
    Table 117. IPCA Laboratories Description and Major Businesses
    Table 118. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 119. IPCA Laboratories Drugs for Malaria Product
    Table 120. IPCA Laboratories Recent Developments
    Table 121. GlaxoSmithKline Corporation Information
    Table 122. GlaxoSmithKline Description and Major Businesses
    Table 123. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 124. GlaxoSmithKline Drugs for Malaria Product
    Table 125. GlaxoSmithKline Recent Developments
    Table 126. Mylan Labs Corporation Information
    Table 127. Mylan Labs Description and Major Businesses
    Table 128. Mylan Labs Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 129. Mylan Labs Drugs for Malaria Product
    Table 130. Mylan Labs Recent Developments
    Table 131. Roche Corporation Information
    Table 132. Roche Description and Major Businesses
    Table 133. Roche Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 134. Roche Drugs for Malaria Product
    Table 135. Roche Recent Developments
    Table 136. Novartis Corporation Information
    Table 137. Novartis Description and Major Businesses
    Table 138. Novartis Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 139. Novartis Drugs for Malaria Product
    Table 140. Novartis Recent Developments
    Table 141. Sanofi Aventis Corporation Information
    Table 142. Sanofi Aventis Description and Major Businesses
    Table 143. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 144. Sanofi Aventis Drugs for Malaria Product
    Table 145. Sanofi Aventis Recent Developments
    Table 146. Ajanta Pharma Corporation Information
    Table 147. Ajanta Pharma Description and Major Businesses
    Table 148. Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 149. Ajanta Pharma Drugs for Malaria Product
    Table 150. Ajanta Pharma Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Drugs for Malaria Distributors List
    Table 154. Drugs for Malaria Customers List
    Table 155. Drugs for Malaria Market Trends
    Table 156. Drugs for Malaria Market Drivers
    Table 157. Drugs for Malaria Market Challenges
    Table 158. Drugs for Malaria Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drugs for Malaria Product Picture
    Figure 2. Global Drugs for Malaria Market Share by Type in 2020 & 2027
    Figure 3. Aryl Aminoalcohol Compounds Product Picture
    Figure 4. Antifolate Compounds Product Picture
    Figure 5. Artemisinin Compounds Product Picture
    Figure 6. Global Drugs for Malaria Sales Market Share by Application in 2020 & 2027
    Figure 7. Prevention
    Figure 8. Treatment
    Figure 9. Others
    Figure 10. Drugs for Malaria Report Years Considered
    Figure 11. Global Drugs for Malaria Sales 2016-2027 (K Units)
    Figure 12. Global Drugs for Malaria Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Drugs for Malaria Revenue 2016-2027 (US$ Million)
    Figure 14. Global Drugs for Malaria Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 15. Global Drugs for Malaria Sales Market Share by Region (2016-2021)
    Figure 16. Global Drugs for Malaria Sales Market Share by Region (2022-2027)
    Figure 17. North America Drugs for Malaria Sales YoY (2016-2027) & (K Units)
    Figure 18. North America Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
    Figure 19. Europe Drugs for Malaria Sales YoY (2016-2027) & (K Units)
    Figure 20. Europe Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
    Figure 21. Asia-Pacific Drugs for Malaria Sales YoY (2016-2027) & (K Units)
    Figure 22. Asia-Pacific Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
    Figure 23. Latin America Drugs for Malaria Sales YoY (2016-2027) & (K Units)
    Figure 24. Latin America Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. Middle East & Africa Drugs for Malaria Sales YoY (2016-2027) & (K Units)
    Figure 26. Middle East & Africa Drugs for Malaria Revenue YoY (2016-2027) & (US$ Million)
    Figure 27. The Top 10 and Top 5 Players Market Share by Drugs for Malaria Sales in 2020
    Figure 28. The Top 10 and Top 5 Players Market Share by Drugs for Malaria Revenue in 2020
    Figure 29. Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 30. Global Drugs for Malaria Sales Market Share by Type (2016-2027)
    Figure 31. Global Drugs for Malaria Revenue Market Share by Type (2016-2027)
    Figure 32. Global Drugs for Malaria Sales Market Share by Application (2016-2027)
    Figure 33. Global Drugs for Malaria Revenue Market Share by Application (2016-2027)
    Figure 34. North America Drugs for Malaria Sales Market Share by Type (2016-2027)
    Figure 35. North America Drugs for Malaria Revenue Market Share by Type (2016-2027)
    Figure 36. North America Drugs for Malaria Sales Market Share by Application (2016-2027)
    Figure 37. North America Drugs for Malaria Revenue Market Share by Application (2016-2027)
    Figure 38. North America Drugs for Malaria Sales Share by Country (2016-2027)
    Figure 39. North America Drugs for Malaria Revenue Share by Country (2016-2027)
    Figure 40. U.S. Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 41. Canada Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 42. Europe Drugs for Malaria Sales Market Share by Type (2016-2027)
    Figure 43. Europe Drugs for Malaria Revenue Market Share by Type (2016-2027)
    Figure 44. Europe Drugs for Malaria Sales Market Share by Application (2016-2027)
    Figure 45. Europe Drugs for Malaria Revenue Market Share by Application (2016-2027)
    Figure 46. Europe Drugs for Malaria Sales Share by Country (2016-2027)
    Figure 47. Europe Drugs for Malaria Revenue Share by Country (2016-2027)
    Figure 48. Germany Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 49. France Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 50. U.K. Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 51. Italy Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 52. Russia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 53. Asia Pacific Drugs for Malaria Sales Market Share by Type (2016-2027)
    Figure 54. Asia Pacific Drugs for Malaria Revenue Market Share by Type (2016-2027)
    Figure 55. Asia Pacific Drugs for Malaria Sales Market Share by Application (2016-2027)
    Figure 56. Asia Pacific Drugs for Malaria Revenue Market Share by Application (2016-2027)
    Figure 57. Asia Pacific Drugs for Malaria Sales Share by Region (2016-2027)
    Figure 58. Asia Pacific Drugs for Malaria Revenue Share by Region (2016-2027)
    Figure 59. China Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 60. Japan Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 61. South Korea Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 62. India Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 63. Australia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 64. Taiwan Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 65. Indonesia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 66. Thailand Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 67. Malaysia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 68. Philippines Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 69. Latin America Drugs for Malaria Sales Market Share by Type (2016-2027)
    Figure 70. Latin America Drugs for Malaria Revenue Market Share by Type (2016-2027)
    Figure 71. Latin America Drugs for Malaria Sales Market Share by Application (2016-2027)
    Figure 72. Latin America Drugs for Malaria Revenue Market Share by Application (2016-2027)
    Figure 73. Latin America Drugs for Malaria Sales Share by Country (2016-2027)
    Figure 74. Latin America Drugs for Malaria Revenue Share by Country (2016-2027)
    Figure 75. Mexico Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 76. Brazil Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 77. Argentina Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 78. Middle East and Africa Drugs for Malaria Sales Market Share by Type (2016-2027)
    Figure 79. Middle East and Africa Drugs for Malaria Revenue Market Share by Type (2016-2027)
    Figure 80. Middle East and Africa Drugs for Malaria Sales Market Share by Application (2016-2027)
    Figure 81. Middle East and Africa Drugs for Malaria Revenue Market Share by Application (2016-2027)
    Figure 82. Middle East and Africa Drugs for Malaria Sales Share by Country (2016-2027)
    Figure 83. Middle East and Africa Drugs for Malaria Revenue Share by Country (2016-2027)
    Figure 84. Turkey Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 85. Saudi Arabia Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 86. U.A.E Drugs for Malaria Revenue (2016-2027) & (US$ Million)
    Figure 87. Drugs for Malaria Value Chain
    Figure 88. Drugs for Malaria Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global GC and GC MS Market Insights and Forecast to 2028
Global GC and GC-MS Market Insights and Forecast to 2028

Chromatography is a technique for separating chemical substances that relies on differences in partitioning behaviour between a flowing mobile phase and a stationary phase to separate the components in a mixture.Market Analysis and Insights Global GC and GCMS MarketDue to the COVID19 pandemic the global GC and GCMS market size is estimated to be worth US 1609.2 million in 2022 and is forecast to a readjusted size of US 2144.2 million by 2028 with a CAGR of 4.9 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-7K9415
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global Oxaliplatin Market Insights and Forecast to 2028
Global Oxaliplatin Market Insights and Forecast to 2028

It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.In this report only the finished drug is covered exclude API.Market Analysis and Insights Global Oxaliplatin MarketThe global Oxaliplatin market size is projected to reach US 1641.5 million by 2028 from US 897.5 million in 2021 at a CAGR of 8.9 during 20222028.Europe is the largest market with about 33 market share.

120 Pages
Type: Report
Code: QYRE-Auto-5N9258
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global Antibody drug Conjugates Market Insights and Forecast to 2028
Global Antibody-drug Conjugates Market Insights and Forecast to 2028

By combining the unique targeting of mAbs with the cancerkilling ability of cytotoxic drugs ADCs allow sensitive discrimination between healthy and diseased tissue.Market Analysis and Insights Global Antibodydrug Conjugates MarketDue to the COVID19 pandemic the global Antibodydrug Conjugates market size is estimated to be worth US 2975.7 million in 2022 and is forecast to a readjusted size of US 3919.8 million by 2028 with a CAGR of 4.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-31N9042
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global MALDI TOF Mass Spectrometer Market Insights and Forecast to 2028
Global MALDI-TOF Mass Spectrometer Market Insights and Forecast to 2028

While Biopharmaceuticals Companies segment is altered to an CAGR throughout this forecast period.Global MALDITOF Mass Spectrometer Market Insights and Forecast to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-4S9413
Sun Jan 09 00:00:00 UTC 2022

Add to Cart